Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

SciBase Q2’24: Forward - but positive cash flow still in the distance

Scibase Holding

Important partnerships established in the USA, first order received from Austria. Cash burn is still high. Analyst Antti Luiro summarizes.

00:00 Intro
00:14 Q2 summary
01:41 Partnership with Unified Health
03:01 First order from Austria
04:28 Cash position
06:42 No news on insurance reimbursement
07:12 Valuation & recommendation

Read our latest report: Still waiting for more signals of accelerating growth 

Stay up to date
Analyst Interviews

Recent videos

Scanfil press conference
23.01.2026, 13.00 Scanfil
AKTIER MED FRIIS - UGE 4 2026
23.01.2026, 12.00
HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian
23.01.2026, 09.17 Pandora
HCA Morgenbørs 21/01 - Positivt futures-marked og fokus på møderne i Davos og kursmål
21.01.2026, 09.25 Genmab
Admicom, Webcast, Q4'25
21.01.2026, 09.00 Admicom
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.